Myriad Genetics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $1.56B
Liabilities Breakdown FY2019
Total Liabilities: $473.8M
Asset Breakdown
Total Assets: $1.56B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $93.2M | 6.0% |
| Accounts Receivable | $133.9M | 8.6% |
| Inventory | $31.4M | 2.0% |
| Property, Plant & Equipment | $57.3M | 3.7% |
| Goodwill | $417.2M | 26.7% |
| Intangible Assets | $684.7M | 43.8% |
| Other Assets | $145.0M | 9.3% |
Liabilities Breakdown
Total Liabilities: $473.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $33.3M | 7.0% |
| Long-Term Debt | $233.5M | 49.3% |
| Other Liabilities | $207.0M | 43.7% |